VICTORIA BIERMAN: Open Payments
NPI 1407810484 · BLACKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,283 in 59 payments from 14 companies in 2025. Trend: 2023 $398 · 2024 $697 · 2025 $1,283
Food & beverage: $1,283
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 8 | $203 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $177 |
| Janssen Pharmaceuticals, Inc | 7 | $170 |
| Teva Pharmaceuticals USA, Inc. | 6 | $168 |
| Neurocrine BioSciences, Inc. | 6 | $124 |
| Lundbeck LLC | 4 | $75 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Alkermes, Inc. | 4 | $62 |
| ABBVIE INC. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
Products named: COBENFY, CAPLYTA, INVEGA SUSTENNA, UZEDY, INGREZZA, ABILIFY MAINTENA, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
